Greycoat Research Dev

Learn

News

Veterinarian Tarkan Özçetin Discusses Specialized Feline Care in New Greycoat Research Interview

Veterinarian Tarkan Özçetin Discusses Specialized Feline Care in New Greycoat Research Interview

Greycoat Research has released a new interview video featuring Veterinarian Tarkan Özçetin, a leading feline veterinarian in Türkiye’s. The interview focuses on feline medicine, specialized cat hospitals, long-term ca...

Greycoat Research Strengthens Clinical R&D Through Strategic Advisory Partnership in Japan

Greycoat Research Strengthens Clinical R&D Through Strategic Advisory Partnership in Japan

Partners with Kobayashi Animal Hospital to advance feline kidney health research, clinical insight, and global scientific collaboration Greycoat Research was recently featured in a media article highlighting its conti...

Greycoat Research Enters Turkey with 3-Year Exclusive Feline Kidney Health Partnership

Greycoat Research Enters Turkey with 3-Year Exclusive Feline Kidney Health Partnership

Greycoat Research was recently featured in a media article highlighting its expanding global footprint in feline kidney care. Greycoat Research has now entered the Turkish market through a three-year exclusive agreeme...

New Launch: Low Protein Salmon Treat for CKD Cats

New Launch: Low Protein Salmon Treat for CKD Cats

For guardians caring for a cat with chronic kidney disease (CKD), few things are as difficult as finding safe, enjoyable treats. Most commercial treats are high in protein and phosphorus, which can place extra strain ...

Direct U.S. Shipping Begins September 30 – Limited Availability

Direct U.S. Shipping Begins September 30 – Limited Availability

We are excited to share some special news with you.Starting September 30, 2025 (KST), Greycoat Research will begin offering direct shipments within the United States for a limited quantity of products.🚚 Only up to 100...

Japan Launches First Nationwide Trial of AIM-Based Kidney Drug for Cats

Japan Launches First Nationwide Trial of AIM-Based Kidney Drug for Cats

Dr. Toru Miyazaki (宮崎徹博士) of the AIM Medical Research Institute, who has been leading the development of a feline kidney disease treatment based on the AIM protein, announced in June the launch of a nationwide clinica...